EWEugenia Wang

Eugenia Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Eugenia Wang has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Harshini Sarojini

    Department of Surgery, University of Louisville, Louisville, Kentucky, United States of America

    7 shared publications
  • Olivier C. Maes

    6 shared publications
  • Richard Marcotte

    The Bloomfield Center for Research in Aging, Lady Davis Institute for Medical Research, The Sir Mortimer B. Davis-Jewish General Hospital, and Department of Medicine, McGill University, Montréal, Québec, Canada

    5 shared publications
  • Suying Xu

    B Department of Biochemistry and Molecular Biology, University of Louisville School of Medicine, Louisville, KY, USA

    5 shared publications
  • Chantale Lacelle

    Department of Biochemistry and Molecular Biology University of Louisville School of Medicine Kentucky

    4 shared publications
  • Howard M. Chertkow

    4 shared publications

Latest Publications

  • Open Access

    Circulatory miR-34a as an RNA-based, noninvasive biomarker for brain aging

    by Xiaoli Li, Amit Khanna, Na Li, Eugenia Wang

    MicroRNAs in blood samples have been identified as an important class of biomarkers, which can reflect physiological changes from cancer to brain dysfunction. In this report we identify concordant increases in levels of expression of miR-34a in brain and two components of mouse blood samples, peripheral blood mononuclear cells (PBMCs) and plasma, from 2 day old neonates through young adulthood and mid-life to old age at 25 months. Levels of this microRNA's prime target, silent information regulator 1 (SIRT1), in brain and the two blood-derived specimens decrease with age inversely to miR-34a, starting as early as 4 months old, when appreciable tissue aging has not yet begun. Our results suggest that: 1. Increased miR-34a and the reciprocal decrease of its target, SIRT1, in blood specimens are the accessible biomarkers for age-dependent changes in brain; and 2. these changes are predictors of impending decline in brain function, as early as in young adult mice.


  • Open Access

    Post‐transcriptional regulation of IGF1R by key microRNAs in long–lived mutant mice

    by Ruqiang Liang, Amit Khanna, Senthilkumar Muthusamy, Na Li, Harshini Sarojini, John J. Kopchick, Michal M. Masternak, Andrzej Bartke, Eugenia Wang

    Summary: Long‐lived mutant mice, both Ames dwarf and growth hormone receptor gene–disrupted or knockout strains, exhibit heightened cognitive robustness and altered IGF1 signaling in the brain. Here, we report, in both these long‐lived mice, that three up‐regulated lead microRNAs, miR‐470, miR‐669b, and miR‐681, are involved in posttranscriptional regulation of genes pertinent to growth hormone/IGF1 signaling. All three are most prominently localized in the hippocampus and correspond to reduced expression of key IGF1 signaling genes: IGF1, IGF1R, and PI3 kinase. The decline in these genes’ expression translates into decreased phosphorylation of downstream molecules AKT and FoxO3a. Cultures transfected with either miR‐470, miR‐669b, or miR‐681 show repressed endogenous expression of all three genes of the IGF1 signaling axis, most significantly IGF1R, while other similarly up‐regulated microRNAs, including let‐7g and miR‐509, do not induce the same levels of repression. Transduction study in IGF1‐responsive cell cultures shows significantly reduced IGF1R expression, and AKT to some extent, most notably by miR‐681. This is accompanied by decreased levels of downstream phosphorylated forms of AKT and FoxO3a upon IGF1 stimulation. Suppression of IGF1R by the three microRNAs is further validated by IGF1R 3′UTR reporter assays. Taken together, our results suggest that miR‐470, miR‐669b, and miR‐681 are all functionally able to suppress IGF1R and AKT, two upstream genes controlling FoxO3a phosphorylation status. Their up‐regulation in growth hormone signaling‐deficient mutant mouse brain suggests reduced IGF1 signaling at the posttranscriptional level, for numerous gains of neuronal function in these long‐lived mice.


  • Stress Gene Deregulation in Alzheimer Peripheral Blood Mononuclear Cells

    by Olivier C. Maes, Howard M. Chertkow, Eugenia Wang, Hyman M. Schipper


  • Open Access

    Gain of survival signaling by down-regulation of three key miRNAs in brain of calorie-restricted mice

    by Amit Khanna, Senthilkumar Muthusamy, Ruqiang Liang, Harshini Sarojini, Eugenia Wang

    The decline in cognitive robustness with aging can be attributed to complex genetic pathways involving many cellular dysfunctions, cumulative over time, precipitating in frailty and loss of wellness in the elderly brain. The size and health of the neuronal cell population determines cognitive robustness in mammals. A transgenic mouse model over-expressing Bcl-2 has been shown to rescue neurons from naturally occurring cell death (NOCD). Here we show that in the brain of calorie-restricted (CR) mice, there is an age-dependent decreased expression of microRNAs mmu-miR-181a-1*, mmu-miR-30e and mmu-miR-34a, with a corresponding gain in Bcl-2 expression, and decreases in pro-apoptosis genes such as Bax and cleavage of Caspases. Functional characterization shows that these miRNAs repress Bcl-2 expression by the 3'UTR reporter assays, accompanied by loss of this gene's endogenous expression, and a gain in pro-apoptosome-specific proteins. Over-expression of these miRNAs increases the rate of apoptosis, accompanied by a decline in Bcl-2 expression in miRNA-transfected mouse and human cell lines. We report here that down-regulation of miR-34a, -30e, and -181a permits their shared target gene expression (Bcl-2) to remain at a high level without post-transcriptional repression, accompanied by concomitant low levels of Bax expression and Caspase cleaving; this chain event may be a part of the underlying mechanism contributing to the gain in neuronal survival in long-lived CR-fed mice.


  • MicroRNA group disorganization in aging

    by Joel Lanceta, Russell A. Prough, Ruqiang Liang, Eugenia Wang


  • Prosaposin in the secretome of marrow stroma‐derived neural progenitor cells protects neural cells from apoptotic death

    by Na Li, Harshini Sarojini, Jin An, Eugenia Wang

    J. Neurochem. (2010) 112, 1527–1538. Functionally, adult stem cells not only participate in replication and differentiation to various cell lineages, but also may be involved in rescuing cells from apoptosis. Identifying functional factors secreted by stem cells, as well as their target cells, may advance our understanding of stem cells’ multifaceted physiologic functions. Here, we report that mouse bone marrow stromal cell‐derived neuroprogenitor cells (mMSC‐NPC) provide a protective function by secreting a key factor, prosaposin (PSAP), capable of rescuing mature neurons from apoptotic death. This factor is identified as the lead protein in the secretome of mMSC‐NPC cultures by tandem mass spectroscopic profiling, and further validated by western blotting and immunocytochemistry. The secretome of MSC‐NPC reduces toxin‐induced cell death in cultures of rat pheochromocytoma neuronal cells, human ReNcell CX neurons, and rat cortical primary neurons; removal of PSAP by immunodepletion annuls this protective effect. This neuronal protection against toxin treatment was validated further by the recombinant PSAP peptide. Interestingly, the secretome of neuronal culture does not possess such a self‐protective action. We suggest that upon injury, a subgroup of MSCs differentiates into neural/neuronal progenitor cells, and remains in this intermediate stem cell‐like stage, defending injured neighboring mature neurons from apoptosis by secreting PSAP.


  • Open Access

    MicroRNA regulation in Ames dwarf mouse liver may contribute to delayed aging

    by David J. Bates, Na Li, Ruqiang Liang, Harshini Sarojini, Jin An, Michal M. Masternak, Andrzej Bartke, Eugenia Wang

    Summary: The Ames dwarf mouse is well known for its remarkable propensity to delay the onset of aging. Although significant advances have been made demonstrating that this aging phenotype results primarily from an endocrine imbalance, the post‐transcriptional regulation of gene expression and its impact on longevity remains to be explored. Towards this end, we present the first comprehensive study by microRNA (miRNA) microarray screening to identify dwarf‐specific lead miRNAs, and investigate their roles as pivotal molecular regulators directing the long‐lived phenotype. Mapping the signature miRNAs to the inversely expressed putative target genes, followed by in situ immunohistochemical staining and in vitro correlation assays, reveals that dwarf mice post‐transcriptionally regulate key proteins of intermediate metabolism, most importantly the biosynthetic pathway involving ornithine decarboxylase and spermidine synthase. Functional assays using 3′‐untranslated region reporter constructs in co‐transfection experiments confirm that miRNA‐27a indeed suppresses the expression of both of these proteins, marking them as probable targets of this miRNA in vivo. Moreover, the putative repressed action of this miRNA on ornithine decarboxylase is identified in dwarf mouse liver as early as 2 months of age. Taken together, our results show that among the altered aspects of intermediate metabolism detected in the dwarf mouse liver – glutathione metabolism, the urea cycle and polyamine biosynthesis – miRNA‐27a is a key post‐transcriptional control. Furthermore, compared to its normal siblings, the dwarf mouse exhibits a head start in regulating these pathways to control their normality, which may ultimately contribute to its extended healthspan and longevity.


  • Stepwise up‐regulation of MicroRNA expression levels from replicating to reversible and irreversible growth arrest states in WI‐38 human fibroblasts

    by Olivier C. Maes, Harshini Sarojini, Eugenia Wang

    MicroRNAs (miRNAs) are small non‐coding RNAs that regulate diverse genetic expression networks through their control of mRNA stability or translation. Their role in aging mechanisms has been proposed in various model systems. In this report, the expression profiling of 462 human miRNAs in the reversible growth arrest state of quiescence, and irreversible states of replicative senescence and hydrogen peroxide‐induced premature senescence, are compared to young replicating lung fibroblasts. Greater numbers of up‐regulated than down‐regulated miRNAs are observed when cells stop proliferating, particularly in premature senescence, somewhat less in replicative senescence, and less still in quiescence. Several altered miRNA expressions are shared by the three growth arrest states, including the up‐regulation of miR‐34a, ‐624, ‐638 and miR‐377, and the down‐regulation of miR‐365 and miR‐512‐5p. miRNAs up‐regulated in both permanent growth arrest states but not in quiescence include let‐7g, miR‐26a, ‐136, ‐144, ‐195 and miR‐200b. In each of the growth arrest states, miR‐34a and let‐7f have the most robust up‐regulation in H2O2‐induced premature senescence, followed by miR‐638 and miR‐663 in replicative senescence, and finally, miR‐331‐3p and miR‐595 in quiescence. Our comprehensive evaluation of miRNA target correlations with known biomarkers for replicative senescence suggests that miRNAs may repress pathways controlling not only cell cycle traverse and proliferation, but also insulin‐like signaling, DNA repair and apoptosis, all of which are cellular functions deficient in senescent human fibroblasts. J. Cell. Physiol. 221: 109–119, 2009. © 2009 Wiley‐Liss, Inc